Woll et al (2014) provided evidence of distinct cancer stem cells (CSCs) in MDS by tracing all identified somatic mutations in the bulk BM back to the immunophenotypically defined Lin‐CD34+CD38−CD90+ stem cell. Here, CD34 is linked to myelodysplastic syndrome.